Robin Meldrum

Below is a comprehensive archive of press releases from MSF-USA. Use the options in the boxes below to filter results based on your preferences.

Press release

Promising MSF Research Highlights Immense Benefits, Need for Expanded Use of DR-TB Drug Combination

February 14, 2018

New research published today in The Lancet Infectious Diseases journal by the international medical humanitarian organization Doctors Without Borders/Médecins Sans Frontières (MSF) provides strong evidence that a combination of two new drugs for tuberculosis (TB)—the world’s leading infectious disease killer—could be used to treat drug-resistant (DR-TB) forms of the disease.
Press release

MSF and Stop TB Partnership at Global Ministerial Meeting on TB: High TB Prevalence Countries Must Urgently Meet New Global Testing and Treatment Standards

November 15, 2017

Ahead of the first-ever Global Ministerial Conference on “Ending TB” in Moscow, the international medical humanitarian organization Doctors Without Borders/Médecins Sans Frontières (MSF), the Stop TB Partnership, and tens of thousands of supporters called for countries with the most people affected by tuberculosis (TB) to implement the latest international treatment and testing standards by World TB Day, March 24, 2018.
Press release

Governments Must Step Up the Use of Newer Drugs to Fight Multidrug-Resistant TB

October 13, 2017

People with drug-resistant tuberculosis (DR-TB) are still not receiving two newer tuberculosis (TB) drugs, bedaquiline and delamanid, which have shown improved cure rates for the disease, said the international medical humanitarian organization Doctors Without Borders/Médecins Sans Frontières (MSF) at the 48th Union World Conference on Lung Health in Guadalajara, Mexico, where the global TB community is meeting.
Press release

G20 Leaders Must Take Action to Protect Medical Facilities, Tackle Drug-Resistant Infections Including TB, and Better Prepare for Medical Emergencies

July 06, 2017

Ahead of the G20 summit in Hamburg, where global health is on the agenda for the first time, the international medical humanitarian organization Doctors Without Borders/Médecins Sans Frontières (MSF) called on G20 leaders to follow through on the declaration made by their health ministers in late May.
Press release

New Report Reveals Governments are Failing to Prioritize Tuberculosis, the World's Deadliest Infectious Disease

July 05, 2017

Two days ahead of the G20 summit in Germany, the international medical humanitarian organization Doctors Without Borders/Médecins Sans Frontières (MSF) and the Stop TB Partnership released a report that shows countries are lagging behind in tackling tuberculosis (TB), introducing the best diagnostic devices, and implementing globally-recommended policies. The third edition of the “Out of Step” report reviews TB policies and practices in 29[1] countries–which account for 82 percent of the global TB burden–and shows that countries can do much more to prevent, diagnose, and treat people affected by TB.
Press release

G7 Must Take Action to Tackle Key Global Health Issues Like High Drug Prices and Drug-Resistant Infections

May 25, 2017

Ahead of the G7 summit that’s starting tomorrow in Italy, the international medical humanitarian organization Doctors Without Borders/Médecins Sans Frontières (MSF) is urging participating countries to address high medicine prices and drug-resistant infections, which affect people everywhere. Today, across the G7, countries are struggling to pay for new medicines to treat life-threatening illnesses like hepatitis C.
Press release

Doctors Without Borders Urges Pharmaceutical Corporations to Release Clinical Data to Help Develop Urgently Needed New TB Regimens

March 24, 2017

NEW YORK, MARCH 24, 2017—Today, World Tuberculosis Day, Doctors Without Borders/Médecins Sans Frontières’ (MSF) is urging pharmaceutical corporations, Sequella and Pfizer, to provide open access to all existing clinical data on a promising drug, sutezolid, to help accelerate the research and development of urgently needed new, lifesaving TB treatment regimes. This data, if not released, will take years and resources to replicate, further delaying new treatment options for people living with TB.
Press release

Fewer than Five Percent of People in Need are Treated with New TB Drugs, Nearly Four Years After Becoming Available

March 23, 2017

Companies and countries must take urgent action to increase access to these lifesaving treatments
Press release

Health Groups Welcome Johns Hopkins University and Medicines Patent Pool Agreement for Development of Promising New TB Drug

January 24, 2017

While deal marks a critical step in the fight against TB, health groups warn that the deal lacks safeguards that would ensure worldwide affordability
Press release

New MSF-Run Clinical Trial Starts Testing Better Treatment Options for People Living with DR-TB

January 19, 2017

NEW YORK, JANUARY 20, 2017—The international medical humanitarian organization Doctors Without Borders/Médecins Sans Frontières (MSF) began a new clinical trial this week in Uzbekistan to develop a radically improved course of treatment for drug-resistant tuberculosis (DR-TB).

The trial aims to find a treatment regimen for DR-TB that is drastically shorter, more effective, and causes fewer side effects than the current treatment options.

Pages